Ticker > Company >

Sudarshan Pharma Ind share price

Sudarshan Pharma Industries Ltd.

BSE: 543828 SECTOR: Pharmaceuticals & Drugs  18.16 K   7   0

29.39
+0.09 (0.31%)
BSE: 08 Jul 4:00 PM

Price Summary

Today's High

₹ 29.4

Today's Low

₹ 29.3

52 Week High

₹ 53.5

52 Week Low

₹ 8.59

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

707.3 Cr.

Enterprise Value

879.86 Cr.

No. of Shares

24.07 Cr.

P/E

44.55

P/B

5.55

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  5.3

CASH

0.39 Cr.

DEBT

172.96 Cr.

Promoter Holding

57.39 %

EPS (TTM)

₹  0.66

Sales Growth

7.94%

ROE

13.28 %

ROCE

14.25%

Profit Growth

39.82 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year7.94%
3 Year12.06%
5 Year27.7%

Profit Growth

1 Year39.82%
3 Year44.59%
5 Year65.59%

ROE%

1 Year13.28%
3 Year11.58%
5 Year13.49%

ROCE %

1 Year14.25%
3 Year14.38%
5 Year15.29%

Debt/Equity

1.3566

Price to Cash Flow

20.26

Interest Cover Ratio

2.3335

CFO/PAT (5 Yr. Avg.)

0.350101530907523

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 57.39 0.00
Sep 2024 57.39 0.00
Mar 2024 57.39 0.00
Sep 2023 57.39 0.00
Mar 2023 57.39 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has a high promoter holding of 57.39%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 25.2635724493713.

 Limitations

  • The company has shown a poor revenue growth of 12.0604354651073% for the Past 3 years.
  • The company is trading at a high PE of 44.55.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 193.35 357.09 461.33 465.56 502.51
Total Expenditure 186.18 346.17 446.64 442.96 464
Operating Profit 7.17 10.92 14.69 22.6 38.5
Other Income 0.38 0.46 1.12 2.75 2.88
Interest 3.23 3.38 5.4 9.03 15.96
Depreciation 0.74 0.87 0.91 1.23 1.31
Exceptional Items 0 0 0 0 -2.82
Profit Before Tax 3.58 7.14 9.5 15.1 21.29
Tax 0.9 1.89 2.46 3.74 5.41
Net Profit 2.67 5.25 7.04 11.36 15.88
Adjusted EPS (Rs.) 0.28 0.54 0.29 0.47 0.66

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 9.55 9.75 24.07 24.07 24.07
Total Reserves 12.96 20.03 76.92 87.55 107.25
Borrowings 8.41 4.94 12.79 10.49 10.46
Other N/C liabilities 0.16 0.18 0.24 0.47 0.64
Current liabilities 68.13 102.61 118.46 162.27 257.98
Total Liabilities 99.21 137.51 232.47 284.84 400.4
Assets
Net Block 6.21 6.47 19.89 20.57 19.79
Capital WIP 0 0.54 0.01 1.88 6.04
Intangible WIP 0 0 0 0 0
Investments 0.09 0.1 12.44 15.44 32.01
Loans & Advances 5.4 0.94 1.62 1.75 4.48
Other N/C Assets 0 0 0 4.35 4.25
Current Assets 87.51 129.47 198.51 240.85 333.83
Total Assets 99.21 137.51 232.47 284.84 400.4
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 3.58 7.14 9.5 15.1 21.29
Adjustment 3.85 4.08 5.82 9.32 18.93
Changes in Assets & Liabilities -3.91 -13.15 -42 -12.62 -2.46
Tax Paid -0.84 -1.77 -2.11 -2.12 -2.84
Operating Cash Flow 2.67 -3.7 -28.79 9.69 34.91
Investing Cash Flow -1.35 -1.54 -25.65 -9.08 -20.24
Financing Cash Flow -1.44 4.31 65.93 -12.18 -14.41
Net Cash Flow -0.11 -0.93 11.48 -11.58 0.26

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Sep 2023% Mar 2024% Sep 2024% Mar 2025%
promoters 57.39 57.39 57.39 57.39 57.39
devangi hemal mehta 0.95 0.95 0.95 0.95 0.95
hemal v mehta huf 0.68 - 0.68 0.68 0.68
hemal vasantrai mehta 26.60 26.60 26.60 26.60 26.60
jatin vasantrai mehta 0.07 0.07 0.07 0.07 0.07
namrata sachin mehta 0.68 0.68 0.68 0.68 0.68
sachin v mehta huf 0.68 - 0.68 0.68 0.68
sachin vasantrai mehta 27.51 27.51 27.51 27.51 27.51
vasantray ratilal mehta 0.14 0.14 0.20 0.20 0.20
hemal v mehta huf . - 0.68 - - -
indumati v mehta 0.07 0.07 - - -
sachin v mehta huf . - 0.68 - - -
PARTICULARS Mar 2023% Sep 2023% Mar 2024% Sep 2024% Mar 2025%
investors 42.61 42.61 42.61 42.61 42.61
bishwanath prasad agrawal... - - - 1.70 1.07
century india opportunity... - - - - 2.39
coeus global opportunitie... - - - 3.68 3.68
eminence global fund pcc ... - - - - 1.83
multitude growth funds li... - - - - 5.52
nexpact limited - - - - 1.34
radiant global fund - cla... - - - - 2.13
ag dynamic funds limited - - - 3.99 -
eminence global fund pcc-... - - - 2.29 -
radiant global fund-class... - - - 2.13 -
gretex share broking limi... - - 4.03 - -
harish kumar rijhwani 2.24 3.09 2.70 - -
indian infotech and softw... - - 1.53 - -
magicremedi private limit... 2.18 2.18 2.18 - -
neelam sethia - 1.13 1.13 - -
prashant narinderlal chad... - - 1.30 - -
vishwamani tiwari huf - - 2.24 - -
gretex share broking priv... 6.36 3.28 - - -
vishwamani tiwari huf . 2.24 2.24 - - -
wasim javid dalal - 1.91 - - -
yashen jayesh savla - 1.32 - - -
gretex corporate services... 1.76 - - - -
madhghne advisory priva... 1.18 - - - -
pannaben sodha 1.42 - - - -
saint capital fund 2.60 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2023

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q3FY25
Presentation H1FY24

Company News

Sudarshan Pharma Industries informs about trading window closure 30 Jun, 5:38 PM Sudarshan Pharma Industries gets nod to incorporate wholly-owned subsidiary in Canada 20 Jun, 10:41 AM Sudarshan Pharma Industries informs about newspaper publication 26 Apr, 12:31 PM Sudarshan Pharma Industries informs about press release 26 Apr, 12:21 PM Sudarshan Pharma gets nod to incorporate subsidiary in Poland 20 Feb, 10:59 AM Sudarshan Pharma Industries enters into Technology Transfer Agreement with Uttaranchal University 27 Jan, 9:58 AM Sudarshan Pharma Industries gets nod to acquire 100% stake in Cibachem 17 Jan, 10:41 AM Sudarshan Pharma Industries enters into Rent Agreement with Daundi Biological 7 Jan, 3:09 PM Sudarshan Pharma gets nod to acquire stake in Sudarshan Pharma Industries, Singapore 30 Nov, 12:43 PM Sudarshan Pharma Industries informs about acquisition 28 Aug, 12:53 PM Sudarshan Pharma Industries informs about business updates 7 Oct, 3:24 PM Sudarshan Pharma Industries incorporates subsidiary company 25 Aug, 12:59 PM Sudarshan Pharma Industries gets nod to incorporate subsidiary in Gujarat 18 Aug, 5:56 PM Sudarshan Pharma Industries to incorporate subsidiary in Gujarat 14 Aug, 9:39 AM Sudarshan Pharma Industries informs about business update 9 Aug, 2:12 PM Sudarshan Pharma Industries to subscribe 100% stake in Ratna Lifesciences 3 Aug, 10:07 AM Sudarshan Pharma Industries informs about certificate 20 Apr, 10:10 AM Sudarshan Pharma Industries coming with an IPO to raise upto Rs 50.10 crore 8 Mar, 10:56 AM

Sudarshan Pharma Ind Stock Price Analysis and Quick Research Report. Is Sudarshan Pharma Ind an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Sudarshan Pharma Ind and its performance over the period of time. Sudarshan Pharma Ind stock price today is Rs 29.39.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Sudarshan Pharma Ind cash from the operating activity was Rs 34.906 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Sudarshan Pharma Ind has a Debt to Equity ratio of 1.3566 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Sudarshan Pharma Ind , the EPS growth was 39.8262 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Sudarshan Pharma Ind has OPM of 7.66212974359537 % which is a bad sign for profitability.
     
  • ROE: Sudarshan Pharma Ind have a average ROE of 13.2802 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Sudarshan Pharma Ind is Rs 29.39. One can use valuation calculators of ticker to know if Sudarshan Pharma Ind share price is undervalued or overvalued.
Last Updated on:
Brief about Sudarshan Pharma Ind
X